首页 | 本学科首页   官方微博 | 高级检索  
检索        

达努塞替对HL-60细胞抗肿瘤作用机制的研究
引用本文:何思佳,舒莉萍,任涛,何志旭.达努塞替对HL-60细胞抗肿瘤作用机制的研究[J].中国病理生理杂志,2016,32(6):990-997.
作者姓名:何思佳  舒莉萍  任涛  何志旭
作者单位:1. 贵州医科大学附属医院儿科, 贵州 贵阳 550001;
2. 第三军医大学大坪医院肿瘤科, 重庆 400042
基金项目:国家自然科学基金资助项目(No.31460312)
摘    要:目的:探讨丝氨酸/苏氨酸激酶抑制剂达努塞替对人急性髓细胞白血病(AML)细胞株HL-60的细胞周期阻滞、自噬和凋亡的影响。方法:用MTT法检测达努塞替对HL-60细胞的生长抑制作用;用流式细胞术检测相同时间不同浓度药物组与同一浓度不同时间组的细胞周期、细胞凋亡及细胞自噬;用Western blot方法检测细胞周期相关蛋白CDK1/CDC2、CDK2、cyclin B1、P21Waf1/Cip1、P27Kip1和P53,凋亡相关蛋白Bcl-x L、Bcl-2、Bax、PUMA、cleaved caspase-3及cleaved caspase-9以及自噬相关蛋白p-PI3K、PTEN、p-Akt、p-m TOR、Beclin 1、LC3-I和LC3-II的水平。用共聚焦显微镜检测同时间不同浓度药物组细胞的自噬情况。结果:达努塞替能明显抑制HL-60细胞的活力,诱导细胞周期G2/M期阻滞,可以通过线粒体caspase-3途径诱导细胞凋亡,同时可以通过抑制PI3K/Akt/m TOR信号通路诱导细胞自噬。结论:达努塞替可通过抑制作为染色体伴侣蛋白且在有丝分裂中调控染色质复制与分离的极光激酶A/B有效抑制HL-60细胞生长,引起细胞周期阻滞、凋亡和自噬发生,可能是AML临床治疗具有前景的抗肿瘤靶点。

关 键 词:PI3K/Akt/mTOR信号通路  细胞周期  细胞凋亡  自噬  HL-60细胞  
收稿时间:2015-12-07

Antitumor mechanism of danusertib in human AML HL-60 cells
HE Si-jia,SHU Li-ping,REN Tao,HE Zhi-xu.Antitumor mechanism of danusertib in human AML HL-60 cells[J].Chinese Journal of Pathophysiology,2016,32(6):990-997.
Authors:HE Si-jia  SHU Li-ping  REN Tao  HE Zhi-xu
Institution:1. Department of Pediatrics, The Affiliated Hospital of Guizhou Medical University, Guizhou 550001, China;
2. Cancer Center, Daping Hospital, Third Military Medical University, Chongqing 400042, China
Abstract:AIM: To investigate the effects of danusertib, a pan-inhibitor of Aurora kinases, on the viability, cell cycle, apoptosis and autophagy of human acute myelocytic leukemia (AML) HL-60 cells.METHODS: The effect of danusertib on the viability of HL-60 cells was examined by MTT assay. The effect of danusertib on apoptosis of HL-60 cells was quantitated by the flow cytometry using an Annexin V/7-AAD apoptosis detection kit. The effect of danusertib on autophagy in the HL-60 cells was assessed by flow cytometry and confocal microscopic analysis. The levels of various proteins related to the cell cycle, apoptosis and autophagy were determined by Western blot.RESULTS: Danusertib decreased the viability of human AML HL-60 cells and induced the cell cycle arrest in G2/M phase. Danusertib also induced mitochon-drium-dependent apoptosis by activation of caspase-3 and autophagy in the HL-60 cells via inhibition of PI3K/Akt/mTOR signaling pathway.CONCLUSION: Danusertib shows effective antitumor ability for promising AML treatment.
Keywords:PI3K/Akt/mTOR signaling pathway  Cell cycle  Apoptosis  Autophagy  HL-60 cells
本文献已被 CNKI 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号